Ethics of controlled human infection to address COVID-19.

Shah SK., Miller FG., Darton TC., Duenas D., Emerson C., Lynch HF., Jamrozik E., Jecker NS., Kamuya D., Kapulu M., Kimmelman J., MacKay D., Memoli MJ., Murphy SC., Palacios R., Richie TL., Roestenberg M., Saxena A., Saylor K., Selgelid MJ., Vaswani V., Rid A.

DOI

10.1126/science.abc1076

Type

Journal article

Journal

Science

Publication Date

22/05/2020

Volume

368

Pages

832 - 834

Keywords

Betacoronavirus, COVID-19, Coronavirus Infections, Drug Development, Human Experimentation, Humans, Pandemics, Pneumonia, Viral, Risk Assessment, SARS-CoV-2, Viral Vaccines

Permalink Original publication